Elon Musk’s Drug Use Allegations Puts Personal Conduct On Board Agendas
The possibility of a CEO using or abusing illegal substances or prescription drugs presents several questions for the boardroom.
The possibility of a CEO using or abusing illegal substances or prescription drugs presents several questions for the boardroom.
Cyber criminals have gone way beyond phishing explorations. Here’s what to look out for—and how to keep your organization safe.
With potential legal action looming, it’s time for board members to have an honest dialogue about what is in the best interest of the company.
The emergence of this new area of attacks against ESG could increase the risk for companies dealing with legitimate shareholder concerns about how environmental and social issues are handled.
Boards should consider how the company will communicate and enforce AI governance rules and policies internally, and ask three key questions.
If alumni could sue like shareholders can sue, they’d have a solid case for malfeasance—especially after this week.
Chief Executive Group exists to improve the performance of U.S. CEOs, senior executives and public-company directors, helping you grow your companies, build your communities and strengthen society. Learn more at chiefexecutivegroup.com.